Si prevede che il mercato dell'irradiazione del sangue raggiungerà i 104,37 milioni di dollari entro il 2028, rispetto ai 65,15 milioni di dollari del 2021; si prevede che crescerà a un CAGR del 7,0% dal 2022 al 2028.
La crescente prevalenza di disturbi trasmissibili e non trasmissibili e l'aumento della ricerca e dello sviluppo guidano la crescita del mercato. Tuttavia, l'elevato costo dell'irradiazione del sangue limita la crescita del mercato.
L'irradiazione del sangue si ottiene esponendo il sangue ad almeno 25 Gy (2500 cGy) di radiazioni al centro del vaso, impedendone la replicazione e attecchimento di leucociti T del donatore immunologicamente competente nel ricevente. La GvHD causata da trapianti da donatori è quasi sempre fatale, quindi i pazienti a rischio dovrebbero ricevere emoderivati irradiati non appena il tempo e le risorse lo consentono. Le indicazioni cliniche, tra cui la leucemia acuta, il linfoma, i tumori solidi sottoposti a chemioterapia o radioterapia intensiva, le exsanguinotrasfusioni, i pazienti sottoposti a trapianto di organi e i neonati prematuri, richiedono una terapia con irradiazione del sangue. I pazienti affetti dal virus dell'immunodeficienza umana/sindrome da immunodeficienza acquisita non necessitano di irradiazione di prodotti sanguigni poiché non è stato segnalato che siano suscettibili alla malattia del trapianto nell'ospite post-trasfusionale.
Approfondimenti strategici
< h3>Regioni redditizie per il mercato dell'irradiazione del sangueApprofondimenti di mercato
L'aumento della prevalenza delle malattie trasmissibili e non trasmissibili stimola la crescita del mercato
Lì Si tratta di un aumento dell’incidenza delle malattie trasmissibili e non trasmissibili, tra cui il cancro, i disturbi cardiovascolari, le malattie renali croniche e l’ictus, a causa dell’ampia popolazione mondiale suscettibile a tali condizioni. Secondo l’Organizzazione Mondiale della Sanità (OMS), i disturbi cardiovascolari sono la principale causa di morte a livello globale e ogni anno vengono segnalati circa 17,9 milioni di decessi. Inoltre, la crescente prevalenza di malattie trasmissibili, come l’epatite, l’influenza, il virus dell’immunodeficienza umana (HIV) e la sindrome da immunodeficienza acquisita (AIDS), stanno guidando la crescita del mercato dell’irradiazione del sangue. Secondo l’OMS, nel 2020 sono state infettate dal virus dell’epatite B 325 milioni di persone e ogni anno 900.000 persone muoiono a causa dell’infezione da virus dell’epatite B. Inoltre, un’ampia popolazione geriatrica in tutto il mondo contribuisce alla prevalenza di malattie non trasmissibili, come disturbi cardiovascolari, disturbi renali e ictus. Secondo l’OMS, la popolazione di persone di età pari o superiore a 60 anni ammontava a 1 miliardo nel 2019 e si prevede che aumenterà fino a 1,4 miliardi entro il 2030 e a 2,1 miliardi entro il 2050. La popolazione anziana è suscettibile a malattie non trasmissibili a causa di vari fattori, come la scarsa alimentazione, mancanza di attività fisica, uso eccessivo di tabacco e consumo di alcol.
Inoltre, l'aumento delle trasfusioni di sangue è dovuto all'aumento delle procedure chirurgiche, degli incidenti, dei casi di traumi e dei disturbi, insieme alla crescente prevalenza delle infezioni del sangue, sostiene la crescita del mercato. Le infezioni del flusso sanguigno, le condizioni sottostanti e le procedure invasive sono comuni tra la popolazione geriatrica. Le infezioni del flusso sanguigno sono la principale causa di malattia e morte tra grandi popolazioni. Secondo la National Library of Medicine, ogni anno nel mondo si verificano circa 28.000 infezioni del sangue. Inoltre, la crescente consapevolezza sulle infezioni del sangue e l’aumento delle risposte immunitarie al sangue trasfuso possono causare complicazioni poiché il crescente utilizzo di sangue irradiato nel trattamento del cancro rafforza il sistema immunitario e migliora la salute generale dei pazienti, il che sta guidando la crescita del mercato dell’irradiazione del sangue.
Pertanto, l'aumento della prevalenza di malattie trasmissibili e non trasmissibili, l'aumento delle trasfusioni di sangue, l'aumento delle infezioni del sangue e l'aumento delle risposte immunitarie stanno guidando la crescita del mercato dell'irradiazione del sangue.
Approfondimenti basati sul tipo
Il mercato dell'irradiazione del sangue, in base al tipo, è segmentato in irradiazione del sangue con laser per via endovenosa, irradiazione del sangue con laser transcutaneo e irradiazione del sangue extracorporea. Nel 2021, il segmento dell’irradiazione laser del sangue per via endovenosa rappresentava la quota di mercato maggiore. Tuttavia, si prevede che il segmento dell'irradiazione laser extracorporea del sangue registrerà il CAGR più elevato, pari al 7,8% durante il periodo di previsione.
Approfondimenti basati sull'utente finale
In base all'utente finale, il mercato dell'irradiazione del sangue è segmentato in ospedali, banche del sangue, cliniche diagnostiche e istituti di ricerca. Il segmento degli ospedali ha detenuto la quota di mercato maggiore nel 2021. Tuttavia, si stima che il segmento delle banche del sangue registrerà il CAGR più elevato del 7,7% nel mercato durante il periodo di previsione.
Approfondimenti basati sulle indicazioni
Per indicazione, il mercato dell'irradiazione del sangue è segmentato in leucemia acuta, tumori solidi, tumori pelvici, linfoma e altri. Il segmento della leucemia acuta ha detenuto la quota di mercato maggiore nel 2021. Tuttavia, si stima che il segmento del linfoma registrerà il CAGR più elevato dell'8,8% nel mercato durante il periodo di previsione.
Mercato dell'irradiazione del sangue, per tipo: 2021 e 2028
Le aziende che operano nel mercato dell'irradiazione del sangue adottano la strategia di innovazione del prodotto per soddisfare le richieste in evoluzione dei clienti in tutto il mondo, che anche consente loro di mantenere il proprio marchio nel mercato globale. Ad esempio, nel giugno 2021, Rad Source Technologies, un fornitore commerciale di prodotti per radiazioni a raggi X negli Stati Uniti, ha progettato un prodotto per sostituire gli irradiatori gamma autoprotetti e ha presentato il suo irradiatore sanguigno RS 3400 recentemente riprogettato al MEDLAB Middle East 2021.
Mercato dell'irradiazione del sangue: per geografia
A livello geografico, il mercato dell'irradiazione del sangue è segmentato in Nord America (Stati Uniti, Canada e Messico), Europa (Francia, Germania, Regno Unito, Spagna, Italia e resto d'Europa), Asia Pacifico (Cina, India, Giappone, Australia, Corea del Sud e resto dell'Asia Pacifico), Medio Oriente e altri paesi. Africa (Arabia Saudita, Emirati Arabi Uniti, Sud Africa e resto del Medio Oriente e dell'Africa) e Sud e Africa. America centrale (Brasile, Argentina e resto dell'America meridionale e centrale). Typenex Medical, LLC; Sistemi medici Hitachi; Tecnologie delle sorgenti radioattive; Gilardoni SpA; Gamma-Service Medical GmbH; Attemio; e Best Theratronics Ltd. sono tra i partecipanti al mercato inclusi nello studio di ricerca.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Blood irradiation is the process in which blood is exposed to low level of radiation which deactivates the T lymphocytes and inhibits the immune response for the prevention of rare graft-versus-host disease (GVHD). This therapy is also used for the treatment of various disorders such as autoimmune disorders, cancer, neuropathies and many more.
Increase in communicable and non-communicable diseases, rise in healthcare expenditure, and government initiatives are the most significant factors responsible for the overall market growth.
Based on type, intravenous laser blood irradiation took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
The acute leukemia segment dominated the global blood irradiation market and accounted for the largest revenue of 26.93 Mn in 2021.
Typenex Medical, LLC; Hitachi Medical Systems; Rad Source Technologies; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Actemium; Best Theratronics Ltd. are among the leading companies operating in the global blood irradiation market
Global blood irradiation market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the U.S. held the largest market share for blood irradiation market. The US is estimated to hold the largest share in the blood irradiation market during the forecast period. Increase in R&D activities along with surge in autoimmune disorders and organ transplants are the contributing factors for the regional growth. Additionally, increase in communicable and non-communicable diseases is the key factor responsible for the Asia-Pacific regional growth for blood irradiation accounting fastest growth of the region during the coming years.
The List of Companies - Blood Irradiation Market
- Typenex Medical, LLC
- Hitachi Medical Systems
- Rad Source Technologies
- Gilardoni S.p.A.
- Gamma-Service Medical GmbH
- Actemium
- Best Theratronics Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jul 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jul 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jul 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)